Eligible subjects will enter the study at a screening visit (Visit 1) and commence a baseline period. Each subject will have a Mayo (including endoscopy) assessment conducted to confirm eligibility. If eligible, the subject will be randomised into the 10-week treatment phase. There are a total of 6 visits in the study.